A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE3TerminatedINTERVENTIONAL
Enrollment

489

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

July 18, 2023

Study Completion Date

July 18, 2023

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Reldesemtiv

Reldesemtiv Oral Tablet

DRUG

Placebo

Placebo Oral Tablet

Trial Locations (84)

9

RSCI Education and Research Centre, Beaumont Hospital, Beaumont

2050

Brain and Mind Centre, Camperdown

2139

Concord Repatriation General Hospital, Concord

2400

Deparment of Neurology Bispebjerg University Hospital, Copenhagen

3000

UZ Leuven Gasthuisberg, Department of Neurology, Leuven

4029

Royal Brisbane and Women's Hospital, Herston

5042

Flinders Medical Centre, Bedford Park

6009

The Perron Institute, Nedlands

9007

Muskelzentrum/ALS Clinic, Sankt Gallen

10021

Hospital for Special Surgery, New York

10032

Columbia University Medical Center, New York

10126

AOU Città della Salute e Scienza (Molinette),, Turin

11361

Studieenheten Akademiskt Specialistcentrum, Sabbatsberg Hospital, Stockholm

13005

CHU de la Timone, Marseille

13210

SUNY Upstate Medical University, Syracuse

13353

Charité - Universitätsmedizin Berlin, Berlin

14642

University of Rochester Medical Center, Rochester

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

19140

Lewis Katz School of Medicine at Temple University, Philadelphia

20037

GW Medical Faculty Associates, Washington D.C.

20138

Instituti Clinici Scientifici Maugeri, Milan

20149

Ospedale San Luca, Milan

20162

Centro Clinical Nemo - Fondazione Serena Onlus, Milan

21287

Johns Hopkins Outpatient Center, Baltimore

21428

Neurologimottagningen Skane University Hospital, Malmo

23233

VCU Neuroscience Orthopaedic and Wellness Center (NOW), Henrico

23538

Universitätsklinikum Schleswig Holstein, Lübeck

28016

Hospital San Rafael, Madrid

28207

Atrium Health Neuroscience Institute - Charlotte, Charlotte

30625

Medical School Hannover - Department of Neurology, Hanover

32209

University of Florida Jacksonville, Jacksonville

32224

Mayo Clinic Florida, Jacksonville

33612

University of South Florida - Carol and Frank Morsani Center for Advanced Health Care, Tampa

37044

CHRU de Tours, Hopital Bretonneau, Clinical Research Center, Tours

37232

Vanderbilt University Medical Center - Clinical Research Center, Nashville

44195

Cleveland Clinic, Cleveland

46026

Hospital Universitari i Politecnic La Fe, Valencia

46202

Indiana University, Indianapolis

48013

Hospital Universitario Basurto, Bilbao

48109

Michigan Medicine, Ann Arbor

48202

Henry Ford Health System, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

53127

Universitatsklinikum Bonn, Bonn

53226

Froedtert Hospital, Milwaukee

59037

CHRU de Lille Hopital Roger Salengro, Lille

60637

Duchossois Center for Advanced Medicine, Chicago

63108

Washington University School of Medicine - Center for Advance Medicine, St Louis

66160

The University of Kansas Medical Center, Kansas City

68506

Neurology Associates, PC, Lincoln

69677

CRC SLA de Lyon, Bron

75013

Hopital La Pitie Salpetriere, Paris

75206

Texas Neurology, P.A., Dallas

80045

University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora

85013

St. Joseph's Hospital & Medical Center - Barrow Neurological Institute, Phoenix

89081

Universitatsklinikum Ulm, Ulm

90048

Cedars-Sinai Medical Center, Los Angeles

92868

University of California Irvine - ALS & Neuromuscular Center, Orange

94109

California Pacific Medical Center - Forbes Norris MDA/ALS Research Center, San Francisco

94305

Stanford Hospital and Clinics, Stanford

97213

Providence ALS Center, Portland

97239

Oregon Health and Science University, Portland

02114

Massachusetts General Hospital - Neurological Clinical Research Institute, Boston

01655

University of Massachusetts Memorial Medical Center/Medical School, Worcester

05401

University of Vermont Medical Center, Burlington

T2N 4Z6

University of Calgary - Heritage Medical Research Clinic, Calgary

T6G 2B7

University of Alberta, Edmonton

E3B 0C7

Stan Cassidy Centre for Rehabilitation, Fredericton

L8N 3Z5

McMaster University Medical Centre, Hamilton

N6A 5A5

London Health Sciences Centre, London

K1Y 4E9

Ottawa Hospital Research Institute - Civic Campus, Ottawa

M4N 3M5

Sunnybrook Research Institute, Toronto

H2X 0A9

Centre de recherche du CHUM, Montreal

H3A 2B4

McGill University, Montreal Neurological Institute & Hospital, Montreal

G1J 1Z4

CHU de Quebec-Université Laval, Québec

S7K 0M7

Saskatoon City Hospital, Saskatoon

87 042

CHU de Limoges - Hopital Dupuytren, Limoges

06 001

CHU de Nice - Hôpital Pasteur 2, Nice

07747

Universitatsklinikum Jena, Jena

3584 CX

UMC Utrecht, Department of Neurology, ALS Center, Utrecht

02-473

City Clinic Research, Warsaw

1649-035

Centro Hospitalar Universitario Lisboa Norte, Department of Neurology, Lisbon

08907

Hospital Universitari de Bellvitge, Barcelona

L9 7LJ

The Walton Centre NHS Foundation Trust, Liverpool

SE5 9RX

Maurice Wohl Clinical Neuroscience Institute, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT04944784 - A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter